(Q37862927)

English

Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction

scientific article published on March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

reperfusion injury

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

Robert A Kloner

2

object named as

Robert A Kloner

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Wangde Dai

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Postgraduate Medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

49-55

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Cardioprotection with angiotensin-converting enzyme inhibitors: redefined for the 1990s

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Impact of acute myocardial ischemia reperfusion on the tissue and blood-borne renin-angiotensin system

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Effect of early versus late AT(1) receptor blockade with losartan on postmyocardial infarction ventricular remodeling in rabbits.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Pretreatment with angiotensin-converting enzyme inhibitors attenuates ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

The angiotensin II type 2 receptor in cardiovascular disease

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

The functional role of the JAK-STAT pathway in post-infarction remodeling

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.03.2263

21 January 2018

Identifiers

10.3810/PGM.2011.03.2263

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37862927&oldid=1740444530"